Four Pharma Stocks That Should Outperform Out To 2016

With a very nervous market, and the end of summer doldrums upon us, it may be time to look for ideas that will make sense when the market heats back up in the fall. One area that looks very intriguing is large cap pharmaceuticals.

Even though they have outperformed the S&P 500 up 8.1% versus the index 1.6%, the top companies are still way under owned by portfolio managers as a percentage of the overall S&P.

Hey, check out all the research scientist jobs. Post your resume today!

MORE ON THIS TOPIC